Why the study?
Does the presence of obstructive non-culprit plaques on coronary CTA predict future MACE in patients with ACS?
Does the presence of obstructive non-culprit plaques on coronary CTA predict future MACE in patients with ACS?
In patients with ACS, the presence of obstructive non-culprit plaques on coronary CTA is an independent predictor of future major adverse cardiovascular events over a nearly 5-year follow-up.
No takes yet. Share an insight, caveat, or question.
Obstructive non-culprit plaques on CTA may refine MACE risk prediction in ACS; extends observational data but should not yet change practice.
Dedic et al. (2014) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: